Real-World Safety and Effectiveness of iGlarLixi in People With Type 2 Diabetes who Fast During Ramadan: Results From Wave 1 of the SOLIRAM Study

Background: People with type 2 diabetes (T2D) are at an increased risk of severe hypoglycaemia when fasting. SOLIRAM is an international, prospective, observational study evaluating the safety and effectiveness of the fixed-ratio combination (FRC) of insulin glargine 100 U/mL and lixisenatide (iGlar...

詳細記述

保存先:
書誌詳細
出版年:J Endocr Soc
主要な著者: Hassanein, Mohamed, Sahay, Rakesh Kumar, Malek, Rachid, Shaltout, Inass, Djaballah, Khier, Demil, Nacima, Chao, Jason, Andersson, Helena M, Buyukbese, Mehmet Akif, Sifri, Saud Al
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2021
主題:
Diabetes Mellitus and Glucose Metabolism
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090142/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.681
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料